Teleflex (NYSE:TFX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings, ...

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Teleflex (NYSE:TFX) in the last three months. The table below provides a snapshot of their ...

As of Thursday, February 26, Teleflex Incorporated’s TFX share price has surged by 7.09%, which has investors questioning if this is right time to sell.

Medical technology company Teleflex (NYSE:TFX) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 28.5% year on year to $569 million. Its non-GAAP profit of $1.93 per share was ...

Teleflex’s second quarter results were marked by positive market reaction, driven largely by operational outperformance in its Interventional segment and effective margin management. Management ...

Teleflex Incorporated (NYSE:TFX) reported better-than-expected earnings for the third quarter on Thursday. The company posted quarterly earnings of $3.67 per share which beat the analyst consensus ...

Teleflex (NYSE:TFX) plans to divest selected businesses and use about US$1b for share repurchases and debt reduction. The company expects these moves to sharpen its portfolio focus and support future ...

Medical technology company Teleflex (NYSE:TFX) will be reporting results tomorrow before market hours. Here’s what to expect.

Tejara Capital Ltd disclosed a buy of 69,700 Teleflex (NYSE:TFX) shares in a February 5 SEC filing, with an estimated transaction value of $8.45 million based on quarterly average pricing. According ...